Your browser doesn't support javascript.
loading
Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma.
Yellapantula, Venkata; Hultcrantz, Malin; Rustad, Even H; Wasserman, Ester; Londono, Dory; Cimera, Robert; Ciardiello, Amanda; Landau, Heather; Akhlaghi, Theresia; Mailankody, Sham; Patel, Minal; Medina-Martinez, Juan Santiago; Arango Ossa, Juan Esteban; Levine, Max Fine; Bolli, Niccolo; Maura, Francesco; Dogan, Ahmet; Papaemmanuil, Elli; Zhang, Yanming; Landgren, Ola.
Afiliación
  • Yellapantula V; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Hultcrantz M; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. hultcram@mskcc.org.
  • Rustad EH; Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden. hultcram@mskcc.org.
  • Wasserman E; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Londono D; Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Cimera R; Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Ciardiello A; Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Landau H; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Akhlaghi T; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Mailankody S; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Patel M; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Medina-Martinez JS; Center for Hematological Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Arango Ossa JE; Center for Hematological Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Levine MF; Center for Hematological Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Bolli N; Center for Hematological Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Maura F; University of Milan, Department of Oncology and Onco-Hematology, Milan, Italy.
  • Dogan A; Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Medical Oncology and Hematology, Milan, Italy.
  • Papaemmanuil E; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Zhang Y; Hematopathology Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Landgren O; Center for Hematological Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Blood Cancer J ; 9(12): 101, 2019 12 11.
Article en En | MEDLINE | ID: mdl-31827071
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Blood Cancer J Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Blood Cancer J Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos